Liang‐Chih Liu

1.6k total citations
83 papers, 1.2k citations indexed

About

Liang‐Chih Liu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Liang‐Chih Liu has authored 83 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 23 papers in Molecular Biology and 23 papers in Cancer Research. Recurrent topics in Liang‐Chih Liu's work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (8 papers) and Credit Risk and Financial Regulations (7 papers). Liang‐Chih Liu is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (8 papers) and Credit Risk and Financial Regulations (7 papers). Liang‐Chih Liu collaborates with scholars based in Taiwan, United States and Singapore. Liang‐Chih Liu's co-authors include Tzong‐Der Way, Chao-Ming Hung, Chi‐Tang Ho, Jung‐Yie Kao, Hwei-Chung Wang, Yung‐Luen Yu, Jiayan Wu, Ying-Chao Lin, Chih‐Jung Chen and Shao‐Chun Wang and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Liang‐Chih Liu

76 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liang‐Chih Liu Taiwan 19 556 432 377 158 137 83 1.2k
Wen‐Ying Lee Taiwan 22 600 1.1× 334 0.8× 323 0.9× 163 1.0× 160 1.2× 56 1.3k
Jin-Woo Kim South Korea 13 508 0.9× 272 0.6× 256 0.7× 121 0.8× 155 1.1× 40 1.1k
Sachin Kumar India 19 590 1.1× 520 1.2× 275 0.7× 101 0.6× 125 0.9× 64 1.3k
Qi Zhou China 21 1.0k 1.9× 649 1.5× 306 0.8× 85 0.5× 115 0.8× 91 1.5k
Rahman Jamal Malaysia 23 653 1.2× 393 0.9× 189 0.5× 115 0.7× 92 0.7× 67 1.2k
Ling Huang China 16 526 0.9× 450 1.0× 429 1.1× 158 1.0× 210 1.5× 70 1.3k
Jenq-Chang Lee Taiwan 18 758 1.4× 374 0.9× 242 0.6× 83 0.5× 66 0.5× 31 1.1k
Ge Wang China 20 729 1.3× 335 0.8× 250 0.7× 92 0.6× 96 0.7× 71 1.2k
Rong Ma China 25 1.0k 1.9× 798 1.8× 305 0.8× 131 0.8× 87 0.6× 71 1.6k
Xiaoqin Li China 18 477 0.9× 237 0.5× 504 1.3× 98 0.6× 142 1.0× 68 1.2k

Countries citing papers authored by Liang‐Chih Liu

Since Specialization
Citations

This map shows the geographic impact of Liang‐Chih Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐Chih Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐Chih Liu more than expected).

Fields of papers citing papers by Liang‐Chih Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang‐Chih Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐Chih Liu. The network helps show where Liang‐Chih Liu may publish in the future.

Co-authorship network of co-authors of Liang‐Chih Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Liang‐Chih Liu. A scholar is included among the top collaborators of Liang‐Chih Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang‐Chih Liu. Liang‐Chih Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Shiyu, Ting-Chun Lin, Liang‐Chih Liu, Wen‐Ling Chen, & Ji An Liang. (2024). Intraoperative radiotherapy versus whole breast radiotherapy in early-stage breast cancer: a retrospective outcome analysis based on ASTRO guidelines on PBI. Breast Cancer Research. 26(1). 181–181.
3.
Lin, Hsiang‐Wen, Chih‐Jung Chen, Hwei-Chung Wang, et al.. (2024). Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin. BMC Cancer. 24(1). 195–195.
4.
Liu, Liang‐Chih, Tian‐Shyr Dai, & Lei Zhou. (2023). On the design of bail-in-able bonds from the perspective of non-financial firms. International Review of Economics & Finance. 89. 1136–1155.
5.
Chen, Chih‐Jung, Ting‐Hao Chen, Jason Lei, et al.. (2022). Correlation of ER, PR, and HER2 at the protein and mRNA levels in Asian patients with operable breast cancer. Bioscience Reports. 42(1). 6 indexed citations
6.
Lin, Po‐Han, Ling‐Ming Tseng, Yi‐Hsuan Lee, et al.. (2022). Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders. Journal of the Formosan Medical Association. 121(12). 2538–2547. 11 indexed citations
7.
Wang, Chuan‐Ju, et al.. (2022). Efficient and Robust Combinatorial Option Pricing Algorithms on the Trinomial Lattice for Polynomial and Barrier Options. Mathematical Problems in Engineering. 2022. 1–20. 2 indexed citations
8.
9.
10.
Liu, Liang‐Chih, et al.. (2022). Analyzing interactive call, default, and conversion policies for corporate bonds. Journal of Futures Markets. 42(8). 1597–1638. 1 indexed citations
11.
Liu, Liang‐Chih, et al.. (2022). Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology. International Journal of Medical Sciences. 19(6). 1023–1028. 10 indexed citations
12.
Yeh, Ming-Hsin, Hsiao‐Fan Chen, Tsu‐Shing Wang, et al.. (2021). ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions. Molecular Therapy — Nucleic Acids. 25. 536–553. 17 indexed citations
13.
Huang, Chih‐Hao, Hsiao‐Fan Chen, Chia‐Hung Chen, et al.. (2021). miR‐221 confers lapatinib resistance by negatively regulating p27kip1 in HER2‐positive breast cancer. Cancer Science. 112(10). 4234–4245. 15 indexed citations
14.
Liu, Liang‐Chih, et al.. (2019). Long non-coding RNA HOTAIR in circulatory exosomes is correlated with ErbB2/HER2 positivity in breast cancer. The Breast. 46. 64–69. 57 indexed citations
15.
Hsiao, Chieh-Lun, Liang‐Chih Liu, Tzu‐Ching Shih, et al.. (2018). The Association of Matrix Metalloproteinase-8 Promoter Genotypes in Breast Cancer. Anticancer Research. 38(4). 2181–2185. 10 indexed citations
16.
17.
Chou, An‐Kuo, Chieh-Lun Hsiao, Tzu‐Ching Shih, et al.. (2017). The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan. Anticancer Research. 37(9). 4973–4977. 15 indexed citations
18.
Lin, Po‐Han, Ming‐Hsin Yeh, Liang‐Chih Liu, et al.. (2013). Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy. Journal of Surgical Oncology. 108(6). 352–357. 12 indexed citations
19.
Chen, Su, et al.. (2012). The carcinoembryonic antigen as a potential prognostic marker for neuroendocrine carcinoma of the breast.. PubMed. 32(1). 183–8. 9 indexed citations
20.
Wang, Hwei-Chung, Chia-Wen Tsai, Liang‐Chih Liu, et al.. (2010). Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.. PubMed. 30(12). 5217–21. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen‐Ying Lee Breakdown of academic impact, for papers by Jin-Woo Kim Breakdown of academic impact, for papers by Sachin Kumar Breakdown of academic impact, for papers by Qi Zhou Breakdown of academic impact, for papers by Rahman Jamal Breakdown of academic impact, for papers by Ling Huang Breakdown of academic impact, for papers by Jenq-Chang Lee Breakdown of academic impact, for papers by Ge Wang Breakdown of academic impact, for papers by Rong Ma Breakdown of academic impact, for papers by Xiaoqin Li
Rankless by CCL
2026